RA Capital is one of the few mainstream biotech VCs wading into the psychedelics space. The VC firm has invested in three psychedelics startups since 2021. It's looking for companies with short acting ...
Series B funds will enable clinical development of ATV-1601, an oral allosteric AKT1-selective inhibitor for the treatment of Hereditary ...
Leading Healthcare-Focused Investor Expands Capabilities to Provide Comprehensive Suite of Equity, Debt, Royalty, and Hybrid Financing Solutions for Commercial Stage Companies Industry Veterans Jeremy ...
For a certain hormone deficiency inadequately managed with calcium and vitamin supplements, the only FDA-approved therapy is a daily injection that’s in limited supply and is set to exit the market ...
RA Capital released its latest quarterly 13F fund update with the SEC last week, showcasing new positions in the multi-stage healthcare and life science-focused fund. The Boston-based fund has emerged ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The first fund for "planetary ...
RIO RANCHO, N.M.--(BUSINESS WIRE)--Nature's Toolbox, Inc. (NTx), a life sciences company building next generation platforms to manufacture RNA and protein, announced today that it has raised $47.5M in ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A gene therapy startup backed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results